Pharmafile Logo

News and Press Releases

Yourgene Health Launches IONA Care+ Non-invasive Prenatal Testing Service

Offers expectant parents fully comprehensive prenatal screening test for genetic conditions, including microdeletions 13 February 2025 -- Manchester, UK -- Yourgene Health (part of the Novacyt group of companies), a leading...

Category: Biotechnology, Other, Pharmaceutical
Posted: February 13, 2025

Yourgene Health
info@yourgenehealth.com
Skelton House Lloyd Street North Manchester Science Park M15 6SH United Kingdom

PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics

14 January 2025 – Menlo Park, California US – PacBio (NASDAQ: PACB), a leading provider of highly accurate long-read sequencing solutions, announced a significant publication from Radboud University Medical Center...

Category:
Posted: January 16, 2025

PacBio
support@pacb.com
1305 O’Brien Drive Menlo Park, CA 94025

Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials

9 January 2025 -- Cambridge, UK and Montreal, Canada -- Biofidelity, a leader in innovative genomic solutions, and CellCarta, the global contract research organization (CRO) partner of choice for biopharmaceutical...

Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: January 9, 2025

Biofidelity
5151 McCrimmon Parkway, Suite 230 Morrisville, NC 27560

Breakthrough Gene Editing Technique Offers Hope for Stargardt Disease Patients

8 January 2025 -- Basel, Switzerland -- Researchers have developed a highly efficient gene editing therapy that could potentially treat Stargardt disease, the most common form of inherited macular degeneration....

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: January 8, 2025

The Institute of Molecular and Clinical Ophthalmology Basel
info@iob.ch
Mittlere Strasse 91, CH-4031 Basel, Switzerland

ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement

License agreement provides Université de Montréal access to CRISPR gene editing technology for use across its platform services 1 October 2024 -- Dublin, Ireland, and Montreal, Canada -- ERS Genomics...

Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: October 1, 2024

ERS Genomics
8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland

Broken String Biosciences appoints Steve Becker as Chief Commercial Officer

Appointment brings extensive experience to lead commercial operations and accelerate growth in key global markets Cambridge, UK, 24 July 2024: Broken String Biosciences (“Broken String”), a genomics company driving development...

Category: BioManufacturing
Posted: July 24, 2024

Broken String Biosciences
info@brokenstringbio.com
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR

Deep Genomics Expands Executive Leadership and Operations in Latest Strategic Growth Initiative  

Company announces executive new hires and marks significant momentum with Cambridge, Massachusetts, US, site opening and Toronto, Canada, office expansion   13 June 2024 -- Massachusetts, US -- Deep Genomics, the...

Category: Biotechnology, Other, Pharmaceutical
Posted: June 13, 2024

Deep Genomics
press@deepgenomics.com
480 University Ave, Suite 1300 Toronto, Ontario, Canada, M5G 1V2

First Study Using Biomimetic AI Digital Twins And Multiomics in Genetics Research

Paper on the ground-breaking research by Genzeva, LumaGene, RYLTI, Brigham & Women’s Hospital of Harvard University, and QIAGEN Digital Insights was published this week in the Journal of Molecular Diagnostics 3 April...

Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: April 3, 2024

GENZEVA
hello@genzeva.com
9420 Key West Avenue, Suite 100, Rockville, Maryland